Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Subjects

Subjects :

Humans
Adenine therapeutic use
Drug Resistance, Neoplasm
Piperidines therapeutic use
Tumor Suppressor Protein p53 genetics
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell genetics

Details

Language :

English

ISSN :

1476-5551

Volume :

37

Issue :

4

Database :

MEDLINE

Journal :

Leukemia

Publication Type :

Report

Accession number :

36807650

Full Text :

https://doi.org/10.1038/s41375-023-01845-9